Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination.

Autor: Karime, Christian, Black, Cecily N., Cortes, Pedro, Kwon, Joshua Y., Caldera, Freddy, Crosby, Sheena K., Picco, Michael F., Kinnucan, Jami A., Hashash, Jana G., Farraye, Francis A.
Zdroj: American Journal of Gastroenterology (Lippincott Williams & Wilkins); Oct2024, Vol. 119 Issue 10, p2079-2085, 7p
Databáze: Complementary Index